FormWeb • tildrakizumab

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

tildrakizumab

tildrakizumab

Restricted Ilumya -->restricted to hospital outpatient setting
Restricted Miscellaneous Programs

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Ilumya	INJECTION, SUBCUTANEOUS	100 mg/mL

Comments:

Defer initiation and continuation of therapy to outpatient setting. Usually managed as patient own medication/patient specific prescription. Reimbursement and patient assistance program status to be evaluated prior to drug initiation.

Reviewed: October 2020 (Ilumya)

Last updated: Nov. 2, 2020

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.